Hypoxia-related molecules HIF-1α, CA9, and osteopontin: Predictors of survival in patients with high-grade glioma

Strahlentherapie und Onkologie

Volumn 189, Issue 2, 2013, Pages 147-154

  Erpolat, O P ^a   Gocun, P U ^a   Akmansu, M ^a   Ozgun, G ^a   Akyol, G ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

High grade glioma; Hypoxia; Osteopontin; Prognostic factors; Survival

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OSTEOPONTIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; FEMALE; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OVERALL SURVIVAL; PREDICTION; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CARBONIC ANHYDRASES; CELL HYPOXIA; FEMALE; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; OSTEOPONTIN; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TURKEY; YOUNG ADULT;

EID: 84874050988     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0262-5     Document Type: Article

References (32)

1. th edn. Lippincott Williams&Wilkins, Philadelphia, pp 717-751
2. Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92:317-335
3. Zagzag D, Lukyanov Y, Lan L et al (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221-1232
4. Said HM, Hagemann C, Staab A et al (2007) Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1α in human glioma in vitro and in vivo. Radiother Oncol 83:398-405
5. Höckel M, Vaupel P (2001) Biological consequences of tumor hypoxia. Semin Oncol 28:36-41
6. Le QT, Courter D (2008) Clinical biomarkers for hypoxia targeting. Cancer Met Rev 27:351-362
7. Vordermark D, Brown JM (2003) Endogenous markers of tumor hypoxia. Strahlenther Onkol 179:801-811
8. Staab A, Fleischer M, Loeffler J et al (2011) Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlenther Onkol 187:252-259
9. Le QT, Kong C, Lavori PW et al (2007) Expression and prognostic significance of a panel of tissue hypoxia markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 69:167-175
10. Sreekanthreddy P, Srinivasan H, Kumar DM et al (2010) Identification of potential erum biomarkers of Glioblastoma: Serum Osteopontin levels correlate with poor prognosis. Cancer Epidemiol Biomarkers Prev 19:1409-1422
11. Birner P, Schindl M, Obermair A et al (2000) Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early stage invasive cervical cancer. Cancer Res 60:4693-4696
12. Bos R, Groep P van der, Greijer AE et al (2003) Levels of hypoxia-inducible factor 1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97:1573-1581
13. Schilling D, Bayer C, Emmerich K et al (2012) Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines. Strahlenther Onkol 188:353-358
14. Pennacchietti S, Michieli P, Galluzo M et al (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347-361
15. Wang Y, Yan W, Lu X et al (2011) Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 90:642-648
16. Colin C, Baeza N, Bartoli C et al (2006) Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using supression subtractive hybridization. Oncogene 25:2818-2826
17. Coppola D, Szabo M, Boulware D et al (2004) Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histogenesis. Clin Cancer Res 10:184-190
18. Matusan K, Dordevic G, Stipic D et al (2006) Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma. J Surg Oncol 94:325-331
19. Saitoh Y, Kuratsu J, Takeshima H et al (1995) Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab Invest 72:55-63
20. Scott CB, Scarantino C, Urtasun R et al (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 92-06. Int J Radiat Oncol Biol Phys 40:51-55
21. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732
22. Irie N, Matsuo T, Nagata I (2004) Protocol of radiotherapy for glioblastome according to to the expression of HIF-1. Brain Tumor Pathol 21:1-6
23. Zagzag D, Zhang H, Scalzitti JM et al (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2606-2618
24. Korkolopoulou P, Perdiki M, Tyhmara I et al (2007) Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum Pathol 38:629-638
25. Wykoff CC, Beasley N, Watson PH et al (2001) Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158:1011-1019
26. Matusan-IIijas KM, Behrem S, Jonjie N et al (2008) Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathol Oncol Res 14:293-298
27. Atai NA, Bansal M, Lo C et al (2010) Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology 132:39-48
28. Wang Y, Yan W, Lu X et al (2011) Overexpression of osteopontin induces angiogenesis of endothelial progenitor cell via the avβ3/P13K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 90:642-648
29. Jang T, Savarase T, Low HP et al (2006) Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am J Pathol 168:1676-1685
30. Ding Q, Stewart J Jr, Prince CW et al (2002) Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 62:5336-5343
31. Cefaro GA, Genovesi D, Vinciguerra A et al (2011) Prognostic impact of hemoglobin level and other factors in patients with high grade glioma treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10 year experience at a sinle institution. Strahlanther Onkol 187:778-783
32. Hui EP, Chan ATC, Pezzella F et al (2002) Co-expression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 8:2595-2604